Effect of Adding Vildagliptin to Start of Insulin Treatment in Patients with Type 2 Diabetes.
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 15 Feb 2013
At a glance
- Drugs Vildagliptin (Primary) ; Insulin; Metformin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 20 May 2012 Status changed from recruiting to active, no longer recruiting recruiting as reported by Netherlands Trial Register.
- 15 Jan 2010 Status changed from planning to recruiting as reported by Netherlands Trial Register.
- 28 Oct 2009 New trial record